You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Trend in HIV seroprevalence among male patients with anal disease or with nonanal disease, 2007 - 2011

From: Hospital-based HIV/HSV-2 seroprevalence among male patients with anal disease in Korea: cross sectional study

Year With anal diseases With nonanal diseases
  N (%)a HIV +b HIV seroprevalence per 10,000 N (%)a HIV +b HIV seroprevalence per 10,000
2007 23,861 (58.0) 24 10.1 17,274 (42.0) 0 0
2008 22,581 (54.3) 30 13.3 18,986 (45.7) 1 0.5
2009 26,173 (53.2) 20 7.6 23,000 (46.8) 0 0
2010 27,552 (56.3) 19 6.9 21,378 (43.7) 2 0.9
2011 30,225 (56.4) 23 7.6 23,382 (43.6) 0 0
  1. HIV prevalence was defined as the number of confirmed HIV cases per 10,000 HIV-tested people over a 1-year period.
  2. Nonanal diseases: patients who presented at the hospital with a nonanal disease or for a health checkup.
  3. aN (%): the number of individuals tested for HIV (the proportion of patients with anal disease or nonanal disease).
  4. bHIV+: the number of HIV-infected individuals.